COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Chiffre d’affaires 2018 de 6,5 M€

17/01/2019 - 07:00

En milliers d'euros 2017 2018* CA annuel 9 137 6 513 * Chiffres non audités Le groupe SPINEWAY totalise sur l’année 2018 un chiffre d’affaires de 6 513 k€ qui s’inscrit dans la tendance des trimestres précédents (- 29 [...]

Golden Leaf Holdings Announces Termination of Agreement to Acquire a multi-use “Sweet 16” license and certain other assets in San Jose, California

16/01/2019 - 23:30

PORTLAND, Ore., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]

Assure Holdings Announces Option Issuance

16/01/2019 - 23:30

DENVER, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announces that further to a board meeting held [...]

Golden Leaf Holdings Announces Termination of Agreement to Acquire the Assets of Tahoe Hydroponics

16/01/2019 - 23:00

PORTLAND, Ore., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]

Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins

16/01/2019 - 22:50

- Expression of IL-27 shown to contribute to upregulation of PD-L1, LAG-3, CTLA-4, and TIGIT - Surface Oncology will submit an IND for SRF388, a first-in-class IL-27 antibody, in Q4 2019 CAMBRIDGE, Mass., Jan. 16, 2019 [...]

MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day

16/01/2019 - 22:30

More than 65,000 patients currently pay cash for their daily insulin each month WESTLAKE VILLAGE, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and [...]

Adamis’ Commercial Partner Launches SYMJEPI™ (epinephrine) in the US

16/01/2019 - 22:18

SAN DIEGO, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its marketing and commercial partner, Sandoz Inc. (Sandoz), a Novartis division, has launched SYMJEPI [...]

Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey

16/01/2019 - 22:15

MINNEAPOLIS, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Sharecare names finalists for inaugural Sharecare Awards

16/01/2019 - 22:11

Public voting open for Sharing Care Award until Jan. 25; all Sharecare Award winners revealed on March 14 at special event in Atlanta and via Facebook Live ATLANTA, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Sharecare, the [...]

HTG Launches HTG EdgeSeq Reveal

16/01/2019 - 22:05

HTG EdgeSeq Reveal is a new software product to analyze HTG EdgeSeq Precision Immuno‑Oncology Panel data TUCSON, Ariz., Jan. 16, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life [...]

Pangu BioPharma (an aTyr Pharma Subsidiary) and The Hong Kong University of Science and Technology Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease

16/01/2019 - 22:00

Researchers from The Hong Kong University of Science and Technology credited with important translational science and early discovery work Significant opportunity to replicate collaborative model to develop pipeline of [...]

Medovex Corporation Enters into Securities Purchase Agreement

16/01/2019 - 21:31

Acquisition of RMS Successfully Closed, New Board Members Appointed, and Financing Secured ALPHARETTA, Ga., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today [...]

Generex Announces Record & Payment Dates for NuGenerex Immuno-Oncology Stock Dividend

16/01/2019 - 20:10

-- Share Dividend Declared -- One share of NuGenerex Immuno-Oncology for every 4 Shares of Generex Biotechnology MIRAMAR, FL, Jan. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation ( www [...]

National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma Brain Cancer

16/01/2019 - 19:56

NBTS provides $750,000 award to the Global Coalition for Adaptive Research to help launch innovative clinical trial for glioblastoma patients Boston, MA, Jan. 16, 2019 (GLOBE NEWSWIRE) -- National Brain Tumor Society ( [...]

MediPharm Labs Signs New Cannabis Oil Agreements and Completes First Shipments of Supply in December

16/01/2019 - 19:30

TORONTO, Jan. 16, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS; OTCQB: MLCPF) (the “ Company ” or “ MediPharm Labs ”), the leader in specialized, research-driven cannabis extraction, fully licensed under [...]

Nanobiotix Plans to Conduct Registered Public Offering in the United States

16/01/2019 - 19:05

Nanobiotix Plans to Conduct Registered Public Offering in the United States Paris, France and Cambridge, Massachusetts (USA), January 16, 2019 – NANOBIOTIX SA (Euronext : NANO – ISIN : FR0011341205) announced today that [...]

Nanobiotix envisage de procéder à une offre au public aux Etats-Unis

16/01/2019 - 19:05

Nanobiotix envisage de procéder à une offre au public aux Etats-Unis Paris, France, et Cambridge, Massachusetts (USA) le 16 janvier 2019 – NANOBIOTIX SA (Euronext: NANO – ISIN: FR0011341205), annonce aujourd’hui son [...]

Quell Reports Successful CES 2019

16/01/2019 - 19:00

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix (Nasdaq: NURO) today announced a successful CES 2019, the world’s largest and most influential technology event, which took place January 8 – 11 in Las Vegas [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

16/01/2019 - 18:39

Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 16 janvier 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]